# Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization

> **NCT04702230** · — · TERMINATED · sponsor: **University of Zurich** · enrollment: 32 (actual)

## Conditions studied

- Liver Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT04702230
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-11
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** Treatment practice unexpectedly changed during the course of the study. Majority of follow-up MRI performed in external institutions. Consequently, the planned number of participants could not be reached.
- **Last updated:** 2021-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04702230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04702230, "Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04702230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*